Gland Pharma Rises 2% as USFDA Concludes Inspection at Visakhapatnam Unit
Shares of Gland Pharma Ltd rose 2% to touch a day’s high of Rs 1,800 on 24th June. The rise came after the company announced...
Tag : Gland Pharma Ltd
Gland Pharma Secures USFDA Nod for Latanoprostene Bunod Ophthalmic Solution
Gland Pharma announced on Wednesday, 30 April, that it had received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug...
Nifty Pharma Bleeds Red Over Looming Tariffs Comment
Shares of Indian pharmaceutical businesses, including Gland Pharma Ltd, Laurus Labs Ltd, Glenmark Pharmaceuticals Ltd, and Biocon Ltd, dropped as much as 8% on Monday,...
Gland Pharma Receives Three Observations from USFDA
Gland Pharma Ltd announced on Tuesday, 25 February, that the U.S. Food and Drug Administration (USFDA) has completed a key inspection of its Andhra Pradesh...
Gland Pharma Shares Gain 2% on EIR from USFDA
Shares of Gland Pharma Ltd were trading in the green and 2% higher on 20 January after the company announced receiving Establishment Inspection Report (EIR)...
Gland Pharma Shares Rally 5% on Securing USFDA Approval
Shares of Gland Pharma Ltd rallied 4.99% on 12 December after the company announced securing drug approval from the US Food and Medication Administration (USFDA)....
Gland Pharma Shares Slump 9% as Q1 Earnings Fail to Cheer Investors
Gland Pharma Ltd shares slumped 9% on 7 August after the company announced its quarterly earnings for April-June. The company reported a 25.9% year-on-year decline...
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
Shares of Gland Pharma Ltd slipped 2% and hit an intra-day low of Rs 1,978.40 on 25 July after the company announced that the US...
Gland Pharma Shares Slump 3% as 6.2% Stake Changed Hands via Block Deal
Shares of Gland Pharma Ltd were trading in the red and 3% lower on 19 June after 1.02 crore shares of the company changed hands...
Gland Pharma Shares Sank 7% on Block Deal, 5.5% equity worth Rs 1,590 crore changed hands
The shares of Gland Pharma Limited lowered by 7% on April 9, on a block deal that took place where 90.8 lakh shares, or 5.5%...